Multifunctional nanoparticles for molecular imaging

Journal of the Korean Medical Association

Volumn 52, Issue 2, 2009, Pages 125-134

  Kang, Eunah ^a   Kim, Kwangmeyung ^a   Kwon, Ick Chan ^a  

^a Korea Institute of Science and Technology   (South Korea)

Author keywords

Activatable; Biodistribution; Bioimaging; Multimodality; Nanoparticles; Targeting

Indexed keywords

EID: 79955802670     PISSN: 19758456     EISSN: None     Source Type: Journal    
DOI: 10.5124/jkma.2009.52.2.125     Document Type: Article

References (33)

1. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003;422:37-44. (Pubitemid 36323287)
2. Park K, Kim JH, Nam YS, Lee S, Nam HY, Kim K, Park JH, Kim IS, Choi K, Kim SY, Kwon IC. Effect of polymer molecular weight on the tumor targeting characteristics of selfassembled glycol chitosan nanoparticles. J Control Release 2007;122:305-314. (Pubitemid 47404663)
3. Thapa N, Hong HY, Sangeetha P, Kim IS, Yoo J, Rhee K, Oh GT, Kwon IC, Lee BH. Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis. J Control Release 2008;131:27-33.
4. Hong HY, Lee HY, Kwak W, Yoo J, Na MH, So IS, Kwon TH, Park HS, Huh S, Oh GT, Kwon IC, Kim IS, Lee BH. Phage Display Selection of Peptides that Home to Atherosclerotic Plaques: IL-4 Receptor as a Candidate Target in Atherosclerosis. J Cell Mol Med 2007.
5. Park K, Hong HY, Moon HJ, Lee BH, Kim IS, Kwon IC, Rhee K. A new atherosclerotic lesion probe based on hydrophobically modified chitosan nanoparticles functionalized by the atherosclerotic plaque targeted peptides. J Control Release 2008;128:217-223.
6. Ghoroghchian PP, Frail PR, Susumu K, Blessington D, Brannan AK, Bates FS, Chance B, Hammer DA, Therien MJ. Near-infrared-emissive polymersomes: self-assembled soft matter for in vivo optical imaging. Proc Natl Acad Sci U S A 2005;102:2922-2927. (Pubitemid 40299892)
7. Hwang HY, Kim IS, Kwon IC, Kim YH. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release 2008;128:23-31.
8. Cho YW, Park SA, Han TH, Son DH, Park JS, Oh SJ, Moon DH, Cho KJ, Ahn CH, Byun Y, Kim IS, Kwon IC, Kim SY. In vivo tumor targeting and radionuclide imaging with selfassembled nanoparticles: mechanisms, key factors, and their implications. Biomaterials 2007;28:1236-1247. (Pubitemid 44816372)
9. Min KH, Park K, Kim YS, Bae SM, Lee S, Jo HG, Park RW, Kim IS, Jeong SY, Kim K, Kwon IC. Hydrophobically modified glycol chitosan nanoparticles- encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. J Control Release 2008;127:208-218.
10. Kim JH, Kim YS, Park K, Lee S, Nam HY, Min KH, Jo HG, Park JH, Choi K, Jeong SY, Park RW, Kim IS, Kim K, Kwon IC. Antitumor efficacy of cisplatin-loaded glycol chitosan nanopar-ticles in tumor-bearing mice. J Control Release 2008;127:41-49.
11. Yin H, Lee ES, Kim D, Lee KH, Oh KT, Bae YH. Physicochemical characteristics of pH-sensitive poly (L-histidine)-b-poly (ethylene glycol)/poly (L-lactide)-b-poly (ethylene glycol) mixed micelles. J Control Release 2008;126:130-138.
12. Lee ES, Gao Z, Kim D, Park K, Kwon IC, Bae YH. Super pH-sensitive multifunctional polymeric micelle for tumor pH (e) specific TAT exposure and multidrug resistance. J Control Release 2008;129:228-236.
13. Pham W, Pantazopoulos P, Moore A. Imaging Farnesyl Protein Transferase Using a Topologically Activated Probe. J Am Chem Sco 2006;128:11736-11737. (Pubitemid 44360193)
14. Ntziachristos V, Schellenberger EA, Ripoll J, Yessayan D, Graves E, Bogdanov A, Josephson L, Weissleder R. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc Natl Acad Sci U S A 2004;101:12294-12299. (Pubitemid 39145437)
15. Jaffer FA, Kim DE, Quinti L, Tung CH, Aikawa E, Pande AN, Kohler RH, Shi GP, Libby P, Weissleder R. Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Pro - tease-Activatable Fluorescence Sensor. Circulation 2007;115:2292-2298. (Pubitemid 46685897)
16. Fischer R, Bachle D, Fotin-Mleczek M, Jung G, Kalbacher H, Brock R. A targeted protease substrate for a quantitative determination of protease activities in the endolysosomal pathway. Chembiochem 2006;7:1428-1434. (Pubitemid 44369095)
17. Bremer C, Tung CH, Weissleder R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat Med 2001;7:743-748. (Pubitemid 32588033)
18. Lee S, Cha EJ, Park K, Lee SY, Hong JK, Sun IC, Kim SY, Choi K, Kwon IC, Kim K, Ahn CH. A near-infrared-fluorescencequenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. Angew Chem Int Ed Engl 2008;47:2804-2807.
19. Lee S, Park K, Lee SY, Ryu JH, Park JW, Ahn HJ, Kwon IC, Youn IC, Kim K, Choi K. Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo. Bioconjug Chem 2008;19:1743-1747.
20. Lee S, Park K, Kim K, Choi K, Kwon IC. Activatable imaging probes with amplified fluorescent signals. Chem Commun (Camb) 2008:4250-4260.
21. Weissleder R, Tung CH, Mahmood U, Bogdanov A, Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 1999;17:375-378. (Pubitemid 29166041)
22. Wunder A, Tung CH, Muller-Ladner U, Weissleder R, Mahmood U. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum 2004;50:2459-2465. (Pubitemid 39062705)
23. Law B, Weissleder R, Tung C-H. Mechanism-Based Fluorescent Reporter for Protein Kinase A Detection. ChemBioChem 2005;6:1361-1367. (Pubitemid 41133898)
24. Rabin O, Manuel Perez J, Grimm J, Wojtkiewicz G, Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006;5:118-122. (Pubitemid 43177900)
25. Perez JM, Josephson L, O'Loughlin T, Högemann D, Weissleder R. Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol 2002;20:816-820. (Pubitemid 34836759)
26. von zur Muhlen C, von Elverfeldt D, Moeller JA, Choudhury RP, Paul D, Hagemeyer CE, Olschewski M, Becker A, Neudorfer I, Bassler N, Schwarz M, Bode C, Peter K. Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis. Circulation 2008;118:258-267.
27. Gao X, Yang L, Petros JA, Marshall FF, Simons JW, Nie S. In vivo molecular and cellular imaging with quantum dots. Curr Opin Biotechnol 2005;16:63-72. (Pubitemid 40249760)
28. Kamaly N, Kalber T, Ahmad A, Oliver MH, So PW, Herlihy AH, Bell JD, Jorgensen MR, Miller AD. Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. Bioconjug Chem 2008;19:118-129. (Pubitemid 351213842)
29. Mulder WJ, Castermans K, van Beijnum JR, Oude Egbrink MG, Chin PT, Fayad ZA, Lowik CW, Kaijzel EL, Que I, Storm G, Strijkers GJ, Griffioen AW, Nicolay K. Molecular imaging of tumor angiogenesis using alphavbeta3-integrin targeted multimodal quantum dots. Angiogenesis 2008.
30. Gerstl F, Windischberger C, Mitterhauser M, Wadsak W, Holik A, Kletter K, Moser E, Kasper S, Lanzenberger R. Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET. Neuroimage 2008;41:204-211.
31. Choi JH, Nguyen FT, Barone PW, Heller DA, Moll AE, Patel D, Boppart SA, Strano MS. Multimodal biomedical imaging with asymmetric single-walled carbon nanotube/iron oxide nanoparticle complexes. Nano Lett 2007;7:861-867. (Pubitemid 46717723)
32. Cheon J, Lee JH. Synergistically Integrated Nanoparticles as Multimodal Probes for Nanobiotechnology. Acc Chem Res 2008.
33. Nam HY, Park JH, Kwon IC. Polymer for Bioimaging. Polymer Sci Technol 2008;19:130-137.